Study Summary:
A research study is enrolling those 18 and older with a history of Bipolar Type I for an approved medication for bipolar type 1, to evaluate its effectiveness in treating recurrent acute Manic/Mixed Episodes. Everyone who qualifies to participate receives the study medication at some point during the trial. Psychological evaluations, drug screens and exams are provided at no cost, with compensation of $75 per visit available for time and travel. You may also be eligible for assistance in receiving your anti-psychotic medication immediately following the study, if all requirements of the study are followed.